UA81387C2 - Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive - Google Patents

Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive

Info

Publication number
UA81387C2
UA81387C2 UA2002032519A UA2002032519A UA81387C2 UA 81387 C2 UA81387 C2 UA 81387C2 UA 2002032519 A UA2002032519 A UA 2002032519A UA 2002032519 A UA2002032519 A UA 2002032519A UA 81387 C2 UA81387 C2 UA 81387C2
Authority
UA
Ukraine
Prior art keywords
ethinylestradiol
daily dosage
drospirenone
active agent
composition
Prior art date
Application number
UA2002032519A
Other languages
English (en)
Inventor
Wolfgang Heil
Ralph Lipp
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26153358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA81387(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Priority claimed from PCT/IB2000/001213 external-priority patent/WO2001015701A1/en
Publication of UA81387C2 publication Critical patent/UA81387C2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
UA2002032519A 1999-08-31 2000-08-31 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive UA81387C2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24095399P 1999-08-31 1999-08-31
EP99202826 1999-08-31
PCT/IB2000/001213 WO2001015701A1 (en) 1999-08-31 2000-08-31 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive

Publications (1)

Publication Number Publication Date
UA81387C2 true UA81387C2 (en) 2008-01-10

Family

ID=26153358

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2002032519A UA81387C2 (en) 1999-08-31 2000-08-31 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive

Country Status (11)

Country Link
CN (1) CN1223350C (bg)
BG (2) BG65204B1 (bg)
CA (1) CA2382426C (bg)
EE (1) EE05317B1 (bg)
HR (1) HRP20020258B1 (bg)
IL (2) IL197396A (bg)
MX (1) MXPA02002043A (bg)
NO (3) NO327588B3 (bg)
RU (4) RU2269342C2 (bg)
SK (1) SK287634B6 (bg)
UA (1) UA81387C2 (bg)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1625849A1 (en) * 2004-08-09 2006-02-15 Liconsa, Liberacion Controlada de Sustancias Activas, S.A. Pharmaceutical composition comprising drospirenone and ethynylestradiol
CN101489563A (zh) * 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
RU2618471C2 (ru) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
CN108606963B (zh) * 2017-12-27 2021-05-18 上海长海医院 含有屈螺酮和雌激素的复方避孕贴、制备方法及应用
CN111529482A (zh) * 2020-05-20 2020-08-14 祝培 十一酸睾酮缓释植入剂及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
ES2223081T3 (es) * 1996-07-26 2005-02-16 Wyeth Metodo anticonceptivo oral monofasico y kit que comprende una combinacion de progestina y estrogeno.

Also Published As

Publication number Publication date
RU2010114825A (ru) 2011-10-20
HRP20020258B1 (en) 2007-05-31
RU2449796C2 (ru) 2006-02-10
BG65204B1 (bg) 2007-07-31
MXPA02002043A (es) 2003-08-20
IL200482A0 (en) 2011-07-31
CN1223350C (zh) 2005-10-19
SK287634B6 (sk) 2011-04-05
IL197396A (en) 2010-04-29
EE200900049A (et) 2009-10-15
CN1407895A (zh) 2003-04-02
RU2396082C2 (ru) 2010-08-10
RU2449796C9 (ru) 2007-10-27
NO2010004I1 (no) 2010-03-22
RU2005131868A (ru) 2007-04-20
NO327588B3 (no) 2011-05-16
RU2269342C9 (ru) 2007-10-27
NO327588B1 (no) 2009-08-31
EE05317B1 (et) 2010-08-16
RU2269342C2 (ru) 2006-02-10
BG109749A (bg) 2008-06-30
CA2382426C (en) 2006-02-28
BG106533A (bg) 2002-10-31
HRP20020258A2 (en) 2005-02-28
NO20083854L (no) 2002-04-26
RU2482853C2 (ru) 2013-05-27
SK2572002A3 (en) 2002-11-06
CA2382426A1 (en) 2001-03-08
NO20091809L (no) 2002-04-26

Similar Documents

Publication Publication Date Title
YU14502A (sh) Farmaceutska kombinacija etinilestradiola i drospirenona za primenu kao kontraceptivnog sredstva
BG66095B1 (bg) Хидрофилен състав с контролирано освобождаване съдържащ прежелатинирано нишесте в препарат
UA41401C2 (uk) Фармацевтичний контрацептивний комбінований препарат
NO327588B1 (no) Farmasoytisk sammensetning og preparat omfattende etinylostradiol og drospirenon for anvendelse som antikonsepsjonsmiddel
TW355683B (en) Composition containing micronized nebivolol
YU33099A (sh) Farmaceutska smesa za poboljšanje erektilne disfunkcije kod muškaraca
HUP9904344A2 (hu) Egyfázisú fogamzásgátló eljárás és progesztin és ösztrogén kombinációját tartalmazó kit
AP2003002763A0 (en) Controlled release formulations for oral administration
WO2002011694A3 (en) COMPOSITIONS AND DOSAGE FORMS FOR APPLICATION IN ORAL CAVITY IN THE TREATMENT OF MYCOSIS
CA2347750A1 (en) Pharmaceutical composition containing decursin
HRP20080394T3 (en) Peroral solid dosage form for contraception comprising dienogest and ethinylestradiol
TW200638951A (en) Solid oral pharmaceutical form for contraception
JO2213B1 (en) A pharmaceutical composition for use as a contraceptive method
EA200701091A1 (ru) Противозачаточный фармацевтический препарат
CA2248841A1 (en) Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
ECSP003721A (es) Una composicion farmaceutica para ser usada como anticonceptivo
EP2305267A3 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
TH54054B (th) สารผสมทางเภสัชกรรมสำหรับใช้เป็นยาคุมกำเนิด
HRP20020666B1 (en) Drospirenone for hormone replacement therapy